| Literature DB >> 27354538 |
Mariasole Da Boit1, Rachael Sibson2, Judith R Meakin3, Richard M Aspden2, Frank Thies2, Arduino A Mangoni4, Stuart Robert Gray5.
Abstract
Resistance exercise training is known to be effective in increasing muscle mass in older people. Acute measurement of protein metabolism data has indicated that the magnitude of response may differ between sexes. We compared adaptive responses in muscle mass and function to 18 weeks resistance exercise training in a cohort of older (>65 years) men and women. Resistance exercise training improved knee extensor maximal torque, 4 m walk time, time to complete five chair rises, muscle anatomical cross-sectional area (ACSA) and muscle quality with no effect on muscle fat/water ratio or plasma glucose, insulin, triacylglycerol, IL-6, and TNF-α Differences between sexes were observed for knee extensor maximal torque and muscle quality with greater increases observed in men versus women (P < 0.05). Maximal torque increased by 15.8 ± 10.6% in women and 41.7 ± 25.5% in men, whereas muscle quality increased by 8.8 ± 17.5% in women and by 33.7 ± 25.6% in men. In conclusion, this study has demonstrated a difference in the magnitude of adaptation, of some of the outcome measures employed, in response to 18 weeks of resistance exercise training between men and women. The mechanisms underlying this observation remain to be established.Entities:
Keywords: Aging; exercise; muscle adaptation; sexual dimorphism
Mesh:
Substances:
Year: 2016 PMID: 27354538 PMCID: PMC4923234 DOI: 10.14814/phy2.12834
Source DB: PubMed Journal: Physiol Rep ISSN: 2051-817X
Red blood cell fatty acid composition in men and women before and after the 18‐week resistance exercise period
| Fatty acid (% total fatty acids) | Men ( | Women ( | ||
|---|---|---|---|---|
| Baseline | 18 weeks | Baseline | 18 weeks | |
| Palmitic (C16:0) | 23.56 ± 1.01 | 23.58 ± 1.11 | 24.17 ± 0.80 | 24.01 ± 1.91 |
| Palmitoleic (C16:1) | 0.69 ± 0.47 | 0.67 ± 0.51 | 0.80 ± 0.61 | 0.44 ± 0.43 |
| Stearic (C18:0) | 14.22 ± 0.70 | 14.16 ± 1.15 | 14.11 ± 1.28 | 14.79 ± 1.09 |
| Oleic (C18:1) | 17.33 ± 0.99 | 17.34 ± 1.14 | 18.50 ± 2.57 | 18.09 ± 2.86 |
| Linoleic (C18:2) | 15.58 ± 2.53 | 16.73 ± 2.62 | 15.46 ± 2.27 | 16.62 ± 3.09 |
| Eicosatrienoic (C20:3) | 2.41 ± 0.97 | 2.03 ± 0.89 | 1.80 ± 0.60 | 1.55 ± 0.46 |
| Arachidonic (C20:4) | 12.99 ± 2.04 | 12.89 ± 2.25 | 12.87 ± 1.29 | 12.53 ± 2.39 |
| Eicosapentaenoic (C20:5) | 1.44 ± 0.97 | 1.50 ± 1.33 | 1.47 ± 0.71 | 1.74 ± 0.50 |
| Lignoceric (C24:0) | 1.83 ± 0.26 | 1.56 ± 0.57 | 1.53 ± 0.23 | 1.61 ± 0.50 |
| Nervonic (C24:1) | 2.12 ± 0.35 | 1.84 ± 0.66 | 1.79 ± 0.26 | 1.87 ± 0.46 |
| Docosapentaenoic (C22:5) | 2.67 ± 0.27 | 2.44 ± 0.88 | 2.32 ± 0.43 | 2.93 ± 1.00 |
| Docosahexaenoic (C22:3) | 5.16 ± 1.19 | 5.26 ± 1.40 | 5.18 ± 0.81 | 5.82 ± 0.62 |
Baseline characteristics of men and women
| Men ( | Women ( | |
|---|---|---|
| Age (years) | 71.5 ± 5.1 | 70.9 ± 2.6 |
| Height (cm) | 171.6 ± 8.0 | 160.0 ± 6.7 |
| Weight (kg) | 73.2 ± 11.5 | 66.0 ± 12.7 |
| BMI (kg/m2) | 24.7 ± 2.6 | 25.8 ± 4.6 |
Denotes a significant (P < 0.05) difference between men and women. BMI, body mass index.
Figure 1Four‐meter walk time (A), chair rise time (B), and knee extensor maximal torque (C) in men and women before and after the 18‐week resistance exercise period. * denotes a significant (P < 0.05) interaction effect.
Muscle CSA, fat, and quality in men and women before and after the 18‐week resistance exercise period
| Men ( | Women ( | |||
|---|---|---|---|---|
| Baseline | 18 weeks | Baseline | 18 weeks | |
| ACSA (cm2) | 56.7 ± 8.7 | 58.8 ± 8.6 | 37.1 ± 5.7 | 37.8 ± 6.2 |
| Muscle fat (%) | 8.2 ± 2.0 | 8.0 ± 1.9 | 8.8 ± 2.1 | 8.9 ± 2.1 |
| Muscle quality (torque per cm2) | 1.93 ± 0.49 | 2.58 ± 0.58 | 2.11 ± 0.55 | 2.22 ± 0.42 |
Denotes a significant (P < 0.05) interaction effect.
Plasma measures of glucose, insulin, triacylglycerol, IL‐6, TNF‐α, and calculated HOMA‐IR in men and women before and after the 18‐week resistance exercise period
| Men ( | Women ( | |||
|---|---|---|---|---|
| Baseline | 18 weeks | Baseline | 18 weeks | |
| Glucose (mmol/L) | 5.33 ± 0.49 | 5.14 ± 0.35 | 6.07 ± 1.44 | 6.21 ± 1.64 |
| Insulin (mU/L) | 6.11 ± 2.66 | 5.71 ± 2.52 | 6.96 ± 4.67 | 6.02 ± 3.18 |
| HOMA‐IR | 1.43 ± 0.61 | 1.31 ± 0.61 | 1.89 ± 1.31 | 1.68 ± 0.95 |
| Triacylglycerol (mmol/L) | 0.86 ± 0.25 | 0.89 ± 0.31 | 1.29 ± 0.87 | 1.03 ± 0.32 |
| IL‐6 (pg/mL) | 1.34 ± 0.66 | 0.88 ± 0.24 | 1.77 ± 1.11 | 1.96 ± 1.02 |
| TNF‐ | 4.91 ± 2.61 | 4.62 ± 2.05 | 4.81 ± 2.13 | 4.67 ± 1.89 |